Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| WEAVER GREGORY L | Chief Financial Officer | 1 | $0 | $0 | 2017-12-20 |
| Opko Health, Inc. | 10% Owner | 6 | $0 | $0 | 2017-09-19 |
| FROST PHILLIP MD ET AL | Director, 10% Owner | 5 | $21.4K | $0 | 2017-02-14 |
| Rubin Steven D | Director | 5 | $0 | $0 | 2017-02-14 |
| BRACA JOHN N | Director | 5 | $0 | $0 | 2017-02-14 |
| Waksal Harlan | Director | 5 | $0 | $0 | 2015-11-19 |
| RIOS MIGUEL DE LOS | VP - Research | 1 | $0 | $0 | 2014-11-18 |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | 1 | $0 | $0 | 2014-11-18 |
| SMIDER VAUGHN | Chief Scientific Officer | 1 | $0 | $0 | 2014-11-18 |
| Browne Leslie J | President | 1 | $0 | $0 | 2014-11-18 |
| Dondero Richard S | VP - Preclinical Research | 1 | $0 | $0 | 2014-11-18 |
| THOMPSON JOHN PHD | Scientific Founder | 1 | $0 | $0 | 2014-11-18 |
| BROOKS JOEL | Chief Financial Officer | 1 | $0 | $0 | 2014-11-18 |
| MARTELL RON | Chief Executive Officer | 1 | $0 | $0 | 2014-11-18 |
| RECTOR DAVID | Director | 2 | $0 | $0 | 2014-11-18 |
| FORBES CHRISTOPHER | Director | 2 | $0 | $0 | 2014-11-18 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| WEAVER GREGORY L | Chief Financial Officer | A Award deriv | 2017-12-20 | 2017-12-22 | 399,266 | — | $0 | 399,266 | SEC↗ |
| Opko Health, Inc. | 10% Owner | C Conversion deriv | 2017-09-19 | 2017-11-07 | 66,667 | — | $0 | 0 | SEC↗ |
| Opko Health, Inc. | 10% Owner | C Conversion | 2017-09-19 | 2017-11-07 | 1,250,006 | — | $0 | 15,893,844 | SEC↗ |
| Opko Health, Inc. | 10% Owner | C Conversion deriv | 2017-08-10 | 2017-08-14 | 0 | — | $0 | 0 | SEC↗ |
| Opko Health, Inc. | 10% Owner | C Conversion deriv | 2017-08-10 | 2017-08-14 | 0 | — | $0 | 0 | SEC↗ |
| Opko Health, Inc. | 10% Owner | C Conversion | 2017-08-10 | 2017-08-14 | 1,563,123 | $0.10 | $156.3K | 12,080,139 | SEC↗ |
| Opko Health, Inc. | 10% Owner | C Conversion | 2017-08-10 | 2017-08-14 | 2,563,699 | $0.10 | $256.4K | 14,643,838 | SEC↗ |
| BRACA JOHN N | Director | A Award deriv | 2017-02-14 | 2017-02-16 | 167,045 | $0.11 | $18.4K | 167,045 | SEC↗ |
| FROST PHILLIP MD ET AL | Director | A Award deriv | 2017-02-14 | 2017-02-16 | 109,091 | $0.11 | $12.0K | 109,091 | SEC↗ |
| Rubin Steven D | Director | A Award deriv | 2017-02-14 | 2017-02-16 | 160,227 | $0.11 | $17.6K | 160,227 | SEC↗ |
| BRACA JOHN N | Director | A Award deriv | 2016-06-13 | 2016-06-15 | 89,773 | $0.11 | $9.9K | 89,773 | SEC↗ |
| FROST PHILLIP MD ET AL | Director, 10% Owner | A Award deriv | 2016-06-13 | 2016-06-15 | 78,409 | $0.11 | $8.6K | 78,409 | SEC↗ |
| Rubin Steven D | Director | A Award deriv | 2016-06-13 | 2016-06-15 | 89,773 | $0.11 | $9.9K | 89,773 | SEC↗ |
| BRACA JOHN N | Director | A Award deriv | 2015-11-19 | 2015-11-23 | 42,500 | $0.25 | $10.6K | 42,500 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2015-11-19 | 2015-11-23 | 40,000 | $0.25 | $10.0K | 40,000 | SEC↗ |
| FROST PHILLIP MD ET AL | Director, 10% Owner | A Award deriv | 2015-11-19 | 2015-11-23 | 32,500 | $0.25 | $8.1K | 32,500 | SEC↗ |
| Rubin Steven D | Director | A Award deriv | 2015-11-19 | 2015-11-23 | 40,000 | $0.25 | $10.0K | 40,000 | SEC↗ |
| FROST PHILLIP MD ET AL | Director, 10% Owner | P Buy | 2015-09-29 | 2015-10-01 | 35,000 | $0.61 | $21.4K | 1,598,170 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2015-05-18 | 2015-05-20 | 11,340 | $0.97 | $11.0K | 147,693 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2015-02-19 | 2015-02-23 | 26,552 | $0.54 | $14.3K | 136,353 | SEC↗ |
| BRACA JOHN N | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 5,270 | $0.42 | $2.2K | 77,914 | SEC↗ |
| BRACA JOHN N | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 31,698 | — | $0 | 72,644 | SEC↗ |
| BROOKS JOEL | Chief Financial Officer | A Award deriv | 2014-11-18 | 2014-11-20 | 28,140 | — | $0 | 47,300 | SEC↗ |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | A Award deriv | 2014-11-18 | 2014-11-20 | 28,140 | — | $0 | 28,140 | SEC↗ |
| RIOS MIGUEL DE LOS | VP - Research | A Award deriv | 2014-11-18 | 2014-11-20 | 34,020 | — | $0 | 147,102 | SEC↗ |
| Dondero Richard S | VP - Preclinical Research | A Award deriv | 2014-11-18 | 2014-11-20 | 28,140 | — | $0 | 49,476 | SEC↗ |
| FROST PHILLIP MD ET AL | Director, 10% Owner | A Award deriv | 2014-11-18 | 2014-11-20 | 25,344 | — | $0 | 25,344 | SEC↗ |
| RECTOR DAVID | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 5,270 | $0.42 | $2.2K | 78,650 | SEC↗ |
| RECTOR DAVID | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 31,698 | — | $0 | 73,380 | SEC↗ |
| Rubin Steven D | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 25,344 | — | $0 | 25,344 | SEC↗ |
| Rubin Steven D | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 3,314 | $0.42 | $1.4K | 28,658 | SEC↗ |
| Browne Leslie J | President | A Award deriv | 2014-11-18 | 2014-11-20 | 42,210 | — | $0 | 82,065 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 17,168 | $0.42 | $7.2K | 109,500 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 38,034 | — | $0 | 92,332 | SEC↗ |
| MARTELL RON | Chief Executive Officer | A Award deriv | 2014-11-18 | 2014-11-20 | 56,364 | — | $0 | 456,364 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-11-18 | 2014-11-20 | 42,210 | — | $0 | 42,210 | SEC↗ |
| THOMPSON JOHN PHD | Scientific Founder | A Award deriv | 2014-11-18 | 2014-11-20 | 34,020 | — | $0 | 53,391 | SEC↗ |
| FORBES CHRISTOPHER | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 3,462 | $0.42 | $1.5K | 67,569 | SEC↗ |
| FORBES CHRISTOPHER | Director | A Award deriv | 2014-11-18 | 2014-11-20 | 27,882 | — | $0 | 64,107 | SEC↗ |